Hitting the Target: How T Cells Detect and Eliminate Tumors-Reference-Cited by-同舟云学术

Hitting the Target: How T Cells Detect and Eliminate Tumors

Published:2018-01-08 Issue:2 Volume:200 Page:392-399
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zamora Anthony E.^ORCID,Crawford Jeremy Chase^ORCID,Thomas Paul G.^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference76 articles.

1. Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

2. Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

3. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

4. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.;Kawakami;J. Immunol.,1995

5. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma;Cancers;2024-08-15

2. The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies;Cancers;2024-07-23

3. T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer;Cancer Biology & Therapy;2024-05-27

4. Cancer Nanovaccines: Nanomaterials and Clinical Perspectives;Small;2024-05

5. Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer;Cancer Immunology Research;2024-03-29